Tag | Content |
---|
EnhancerAtlas ID | HS141-12142 |
Organism | Homo sapiens |
Tissue/cell | NB4 |
Coordinate | chr21:40388560-40389700 |
Target genes | |
SNPs | Number: 1 | ID | Chromosome | Position | Genome Version |
|
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
Nr2f6(var.2) | MA0728.1 | chr21:40388959-40388974 | CAGGTCAAGAGGCCA | + | 6.16 |
|
| Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
SE_25426 | chr21:40388581-40389344 | DND41 | SE_53397 | chr21:40388488-40389800 | Spleen | SE_61693 | chr21:40350957-40395280 | Toledo |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH21I039014 | chr21 | 40385981 | 40389130 |
|
Enhancer Sequence | GGTGGAGGTT GCAGCGAGCC AAGATCGTGC CACTGCACTC CAGCCTGGGT GACTGAGCGA 60 GACTCCATCT CAAAAAAAAA AAAATGCTAT CCACAAAGTT GGATAAGTAC AGAAACATTG 120 TCCCAGGAAA TGAAGCCAGT GATTAGGGCA GGGGTTGGCA AGTGTTTTCT GTAAGAACCA 180 CATAGTAAAT ATTTTCGGCT TTTACTGGCC CATTTGGTCT TTGTTGCAAC TGCTCAACTC 240 TGCCATCAAA ATGCAGGCAA CAGCCGTGGA TAATATGTAG TGAATGGGCA TGAGCATTGT 300 CTTAGTTAAT TTTCTGTTGC TTAAAACAGA ATGCCTAAAA CTGGGTCATT TATAAAGAAA 360 AGGAATTTAT TTCTTACAGT TATGGAGGCT GAGAAGTCTC AGGTCAAGAG GCCACATCTG 420 GTGAAGATCC TCTTGCTAGC CAGGACTCTC TACAGAGTCC TGTGGTGGTT GGTGCAGGGC 480 AACCTGTGGT GAGAGGACTC AAGTCTCACT TCCTCTTGCT ACAAAGCCGC CAGTTTCCCT 540 GCCACTGTCT CCCTTCCTCT TCTTACAAAA CTGCCAGTTT CCTTGCGATG ATAAACCACC 600 AATCCATTAA TGCATTAATC CATTAATCCA TGAATAGATT AATCCATTCA TGAGGGCAGA 660 GTTCCCATGC CCCCATCACT TCTTAAAGGC CCTATCTCTT AATATAGTGA CGTTAGAGAC 720 TAAGTTTCAA CATGAGTTTT GGAGAGGACA TTCAAACCAT AGAAGTGTGT TCTAATGAAA 780 CCACGTTTAT GGATGCTAAA ATGTAAACAT ATAATTTTCA TGTTCCACAA AATATTGTTC 840 TTCTTCTGAT GTTTTCCCAC ACTATTAAAA TATAATACTA TGACTAGCTT GTGAGCCACA 900 TGAAAAGAGG CGGCAGGCTA GATTCGGGCT GTGGGCTGCA GTTCGCTGGC ATCTGCTCTA 960 GGGCCACTCT CTCAGTAACA AAAACGTGCA TTCGCCTCTA ATAACACGCA TGTACATGTG 1020 ACACTACTCA AACAGTGAGC AAGCTGAGAC TGAAAAACGT ATCAGTTGAC ACTCCAGAAT 1080 GTTCTTGCTG AAATCCTTCA GTGGATCATC TCATAAAGTC CTGGGAATGC ACGCTGAGGC 1140
|